SCHEMBL4664748

SCHEMBL4664748

O=C(Cn1c2ccccc2c2ccccc21)C1=C(O)C(CCc2ccccc2)NC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
TSPO P30536 2/20 0.40
GLA P06280 1/20 0.40
NR0B1 P51843 1/20 0.39
POLB P06746 1/20 0.39
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
ALB P02768 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4664777 0.82 KMT2A (0.47) KDM4ENR0B1POLBLMNASMN1; SMN2
SCHEMBL4664683 0.80 NR0B1 (0.45) KDM4ENR0B1POLBLMNASMN1; SMN2
SCHEMBL4241441 0.79 NR0B1 (0.48) KDM4ENR0B1POLBLMNASMN1; SMN2
SCHEMBL4664915 0.78 NPC1 (0.48) NR0B1POLBLMNASMN1; SMN2MEN1
SCHEMBL28557461 0.76 NR0B1 (0.52) KDM4ENR0B1POLBLMNASMN1; SMN2
SCHEMBL4663006 0.75 HPGD (0.49) LMNASMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL6029305 0.75 SLC6A2 (0.50) KDM4ELMNASMN1; SMN2MEN1ALDH1A1
SCHEMBL4664917 0.74 NR0B1 (0.46) KDM4ENR0B1POLBLMNASMN1; SMN2
SCHEMBL4664739 0.74 TP53 (0.40) NR0B1POLBLMNASMN1; SMN2L3MBTL1
SCHEMBL4666733 0.74 CDK4 (0.47) LMNASMN1; SMN2MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS GODEL THIERRY 2008-06-05 US claimed
US-20050119329-A1 Tetronic and tetramic acids HOFFMANN-LA ROCHE INC. 2005-06-02 US claimed
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS GODEL THIERRY 2008-06-05 US disclosed
US-20050119329-A1 Tetronic and tetramic acids HOFFMANN-LA ROCHE INC. 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132562-A1 TETRONIC AND TETRAMIC ACIDS BACE1, PSEN1, BACE2 KDM4E 3412/4885TSPO 483/4885GLA 54/4885
US-20050119329-A1 Tetronic and tetramic acids BACE1, PSEN1, BACE2 KDM4E 3412/4885TSPO 483/4885GLA 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.